These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10802512)

  • 21. High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
    Manzar S
    Pediatrics; 2006 May; 117(5):1863; author reply 1863-4. PubMed ID: 16651359
    [No Abstract]   [Full Text] [Related]  

  • 22. Should a prolonged or short course of indomethacin be used in preterm infants to treat patent ductus arteriosus?
    Shah S
    Arch Dis Child; 2003 Dec; 88(12):1132-3. PubMed ID: 14670791
    [No Abstract]   [Full Text] [Related]  

  • 23. The management of symptomatic patient ductus arteriosus in premature infants.
    Ho LY
    J Singapore Paediatr Soc; 1986; 28(1-2):153-62. PubMed ID: 3762074
    [No Abstract]   [Full Text] [Related]  

  • 24. A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants.
    Ojala TH; Lehtonen L
    Pediatr Crit Care Med; 2007 May; 8(3):258-60. PubMed ID: 17496511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of indomethacin in the closure of patent ductus arteriosus in premature newborn infants with cardiac insufficiency. Analysis of 14 cases].
    Atik E; Moromizato JH; Zan R; Ajzenberg M; Esher R; Diniz EM; Souza AT; Martins CO; Bastos JC
    Arq Bras Cardiol; 1984 Sep; 43(3):185-9. PubMed ID: 6535546
    [No Abstract]   [Full Text] [Related]  

  • 28. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic Treatment of Patent Ductus Arteriosus in the Preterm Infant.
    Gregory KE
    J Perinat Neonatal Nurs; 2016; 30(1):6-8. PubMed ID: 26813387
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of an aneurysmal dilatation of the ductus arteriosus with indomethacin in a premature infant.
    Doege C; Linderkamp O; Gorenflo M; Bauer J
    Pediatr Cardiol; 2006; 27(1):166-167. PubMed ID: 16261270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why would a sane clinician not prescribe prophylactic indomethacin?
    DeMauro SB; Schmidt B; Roberts RS
    Acta Paediatr; 2011 May; 100(5):636. PubMed ID: 21352363
    [No Abstract]   [Full Text] [Related]  

  • 33. Indomethacin in closure of patent ductus arteriosus.
    Vedanarayanan VV; Verma IC
    Indian J Pediatr; 1981; 48(393):477-80. PubMed ID: 7327640
    [No Abstract]   [Full Text] [Related]  

  • 34. Indomethacin-associated neutropenia with subsequent Gram-negative sepsis in a preterm infant. Cause or coincidence?
    Bengtsson BO; Milstein JM; Sherman MP
    J Perinatol; 2006 Jun; 26(6):381-3. PubMed ID: 16724081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of the patent ductus arteriosus to indomethacin treatment.
    Goldberg SJ
    Am J Dis Child; 1987 Mar; 141(3):250. PubMed ID: 3812404
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacologic treatment of patent ductus arteriosus.
    Friedman WF
    Adv Cardiol; 1979; 26():65-75. PubMed ID: 420062
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.
    Vert P; Bianchetti G; Marchal F; Monin P; Morselli PL
    Eur J Clin Pharmacol; 1980 Jul; 18(1):83-8. PubMed ID: 7398752
    [No Abstract]   [Full Text] [Related]  

  • 39. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus.
    Salzer HR; Salzer-Muhar U; Pollak A; Weninger M
    Lancet; 1987 Apr; 1(8539):977. PubMed ID: 2882363
    [No Abstract]   [Full Text] [Related]  

  • 40. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.